Dr Metters has 25 years of experience in the discovery and development of novel therapies for the treatment of serious diseases. She is currently working as an independent biopharma consultant and board member. From 2011-2014 she was President and Chief Executive officer for Lycera Corp., a biopharmaceutical company pioneering innovative approaches to novel oral medicines for treatment of autoimmune diseases and cancer. From 1988 to 2011 she was employed by Merck & Co in various roles.
